2018-2023 Global Breast Cancer Monoclonal Antibodies Market Report (Status and Outlook)

September 2018 | 155 pages | ID: 261D71DC48EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Breast Cancer Monoclonal Antibodies market for 2018-2023.

Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates the growth and division of malignant cells.
The breast cancer monoclonal antibodies (mAbs) market is one of the fastest-growing segments of the global mAbs market and has gained major research significance among biotech and pharmaceutical companies due to the presence of high unmet needs in this area. Antibodies are increasingly becoming the best choice to treat cancers, including breast cancer. The use of antibody-drug conjugates (ADCs),including radioimmunotherapy and antibody-directed enzyme prodrug therapy, is increasing rapidly. ADCs are highly effective cytotoxic drugs linked to mAbs. These drugs have shown to be potent and efficient in treating breast cancer. This has propelled vendors to focus on novel technologies such as Seattle Genetics (SGEN), ImmunoGen (IMGN), and Immunomedics (IMMU). The rising use of these antibodies in drug development increases revenue generation in the breast cancer mAbs market, contributing to market growth.
The breast cancer mAbs market in APAC will witness a high growth rate during the forecast period due to the better market penetration of breast cancer mAbs and biosimilars in emerging economies, especially in Japan, Australia, India, South Korea, and China. The rising number of initiatives undertaken by major vendors to assist patients in these countries is a significant contributor to the rise in sales of breast cancer mAbs in these countries. Moreover, the growing awareness about breast cancer and the available treatment alternatives will also propel growth prospects for the market growth in APAC.
Over the next five years, LPI(LP Information) projects that Breast Cancer Monoclonal Antibodies will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Breast Cancer Monoclonal Antibodies market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Naked MAbs
• Conjugated MAbs

Segmentation by application:

• Hospitals
• Retail Pharmacies
• Others

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Amgen
• Roche
• Mylan
• Array BioPharma
• Biocad
• Boehringer Ingelheim
• Bristol-Myers Squibb
• Celldex Therapeutics
• Celltrion
• Daiichi Sankyo
• GlaxoSmithKline
• Immunomedics
• MacroGenics
• Merck
• Novartis
• Oncothyreon
• Pfizer
• Puma Biotechnology
• Seattle Genetics
• Sun Pharmaceutical Industries
• Synta Pharmaceuticals
• Teva Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Breast Cancer Monoclonal Antibodies market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Breast Cancer Monoclonal Antibodies market by identifying its various subsegments.
• Focuses on the key global Breast Cancer Monoclonal Antibodies players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Breast Cancer Monoclonal Antibodies with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Breast Cancer Monoclonal Antibodies submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Breast Cancer Monoclonal Antibodies Market Size 2013-2023
  2.1.2 Breast Cancer Monoclonal Antibodies Market Size CAGR by Region
2.2 Breast Cancer Monoclonal Antibodies Segment by Type
  2.2.1 Naked MAbs
  2.2.2 Conjugated MAbs
2.3 Breast Cancer Monoclonal Antibodies Market Size by Type
  2.3.1 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
  2.3.2 Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate by Type (2013-2018)
2.4 Breast Cancer Monoclonal Antibodies Segment by Application
  2.4.1 Hospitals
  2.4.2 Retail Pharmacies
  2.4.3 Others
2.5 Breast Cancer Monoclonal Antibodies Market Size by Application
  2.5.1 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
  2.5.2 Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate by Application (2013-2018)

3 GLOBAL BREAST CANCER MONOCLONAL ANTIBODIES BY PLAYERS

3.1 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Players
  3.1.1 Global Breast Cancer Monoclonal Antibodies Market Size by Players (2016-2018)
  3.1.2 Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Players (2016-2018)
3.2 Global Breast Cancer Monoclonal Antibodies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BREAST CANCER MONOCLONAL ANTIBODIES BY REGIONS

4.1 Breast Cancer Monoclonal Antibodies Market Size by Regions
4.2 Americas Breast Cancer Monoclonal Antibodies Market Size Growth
4.3 APAC Breast Cancer Monoclonal Antibodies Market Size Growth
4.4 Europe Breast Cancer Monoclonal Antibodies Market Size Growth
4.5 Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Growth

5 AMERICAS

5.1 Americas Breast Cancer Monoclonal Antibodies Market Size by Countries
5.2 Americas Breast Cancer Monoclonal Antibodies Market Size by Type
5.3 Americas Breast Cancer Monoclonal Antibodies Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Breast Cancer Monoclonal Antibodies Market Size by Countries
6.2 APAC Breast Cancer Monoclonal Antibodies Market Size by Type
6.3 APAC Breast Cancer Monoclonal Antibodies Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Breast Cancer Monoclonal Antibodies by Countries
7.2 Europe Breast Cancer Monoclonal Antibodies Market Size by Type
7.3 Europe Breast Cancer Monoclonal Antibodies Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Breast Cancer Monoclonal Antibodies by Countries
8.2 Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Type
8.3 Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL BREAST CANCER MONOCLONAL ANTIBODIES MARKET FORECAST

10.1 Global Breast Cancer Monoclonal Antibodies Market Size Forecast (2018-2023)
10.2 Global Breast Cancer Monoclonal Antibodies Forecast by Regions
  10.2.1 Global Breast Cancer Monoclonal Antibodies Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Breast Cancer Monoclonal Antibodies Forecast by Type
10.8 Global Breast Cancer Monoclonal Antibodies Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Amgen
  11.1.1 Company Details
  11.1.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.1.3 Amgen Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Amgen News
11.2 Roche
  11.2.1 Company Details
  11.2.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.2.3 Roche Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Roche News
11.3 Mylan
  11.3.1 Company Details
  11.3.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.3.3 Mylan Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Mylan News
11.4 Array BioPharma
  11.4.1 Company Details
  11.4.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.4.3 Array BioPharma Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Array BioPharma News
11.5 Biocad
  11.5.1 Company Details
  11.5.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.5.3 Biocad Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Biocad News
11.6 Boehringer Ingelheim
  11.6.1 Company Details
  11.6.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.6.3 Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Boehringer Ingelheim News
11.7 Bristol-Myers Squibb
  11.7.1 Company Details
  11.7.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.7.3 Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Bristol-Myers Squibb News
11.8 Celldex Therapeutics
  11.8.1 Company Details
  11.8.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.8.3 Celldex Therapeutics Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Celldex Therapeutics News
11.9 Celltrion
  11.9.1 Company Details
  11.9.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.9.3 Celltrion Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.9.4 Main Business Overview
  11.9.5 Celltrion News
11.10 Daiichi Sankyo
  11.10.1 Company Details
  11.10.2 Breast Cancer Monoclonal Antibodies Product Offered
  11.10.3 Daiichi Sankyo Breast Cancer Monoclonal Antibodies Revenue, Gross Margin and Market Share (2016-2018)
  11.10.4 Main Business Overview
  11.10.5 Daiichi Sankyo News
11.11 GlaxoSmithKline
11.12 Immunomedics
11.13 MacroGenics
11.14 Merck
11.15 Novartis
11.16 Oncothyreon
11.17 Pfizer
11.18 Puma Biotechnology
11.19 Seattle Genetics
11.20 Sun Pharmaceutical Industries
11.21 Synta Pharmaceuticals
11.22 Teva Pharmaceuticals

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Breast Cancer Monoclonal Antibodies
Figure Breast Cancer Monoclonal Antibodies Report Years Considered
Figure Market Research Methodology
Figure Global Breast Cancer Monoclonal Antibodies Market Size Growth Rate 2013-2023 ($ Millions)
Table Breast Cancer Monoclonal Antibodies Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Naked MAbs
Table Major Players of Conjugated MAbs
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Global Naked MAbs Market Size Growth Rate
Figure Global Conjugated MAbs Market Size Growth Rate
Figure Breast Cancer Monoclonal Antibodies Consumed in Hospitals
Figure Global Breast Cancer Monoclonal Antibodies Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Breast Cancer Monoclonal Antibodies Consumed in Retail Pharmacies
Figure Global Breast Cancer Monoclonal Antibodies Market: Retail Pharmacies (2013-2018) ($ Millions)
Figure Global Retail Pharmacies YoY Growth ($ Millions)
Figure Breast Cancer Monoclonal Antibodies Consumed in Others
Figure Global Breast Cancer Monoclonal Antibodies Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Global Breast Cancer Monoclonal Antibodies Market Size in Hospitals Growth Rate
Figure Global Breast Cancer Monoclonal Antibodies Market Size in Retail Pharmacies Growth Rate
Figure Global Breast Cancer Monoclonal Antibodies Market Size in Others Growth Rate
Table Global Breast Cancer Monoclonal Antibodies Revenue by Players (2016-2018) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Players (2016-2018)
Figure Global Breast Cancer Monoclonal Antibodies Revenue Market Share by Players in 2017
Table Global Breast Cancer Monoclonal Antibodies Key Players Head office and Products Offered
Table Breast Cancer Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Breast Cancer Monoclonal Antibodies Market Size by Regions 2013-2018 ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Regions 2013-2018
Figure Global Breast Cancer Monoclonal Antibodies Market Size Market Share by Regions 2013-2018
Figure Americas Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size 2013-2018 ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table Americas Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table Americas Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Americas Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure United States Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Canada Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table APAC Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table APAC Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure China Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Japan Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Korea Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure India Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Australia Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table Europe Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure Germany Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure France Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure UK Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Italy Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Russia Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Spain Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Countries in 2017
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Type in 2017
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size Market Share by Application in 2017
Figure Egypt Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Israel Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Breast Cancer Monoclonal Antibodies Market Size Growth 2013-2018 ($ Millions)
Figure Global Breast Cancer Monoclonal Antibodies arket Size Forecast (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share Forecast by Regions
Figure Americas Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure APAC Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Europe Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure United States Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Canada Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Mexico Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Brazil Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure China Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Japan Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Korea Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure India Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Australia Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Germany Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure France Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure UK Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Italy Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Russia Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Spain Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Egypt Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure South Africa Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Israel Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure Turkey Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Figure GCC Countries Breast Cancer Monoclonal Antibodies Market Size 2018-2023 ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share Forecast by Type (2018-2023)
Table Global Breast Cancer Monoclonal Antibodies Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Breast Cancer Monoclonal Antibodies Market Size Market Share Forecast by Application (2018-2023)
Table Amgen Basic Information, Head Office, Major Market Areas and Its Competitors
Table Amgen Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Amgen Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Roche Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Roche Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mylan Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Mylan Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Array BioPharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Array BioPharma Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Array BioPharma Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Biocad Basic Information, Head Office, Major Market Areas and Its Competitors
Table Biocad Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Biocad Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Boehringer Ingelheim Basic Information, Head Office, Major Market Areas and Its Competitors
Table Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Boehringer Ingelheim Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Bristol-Myers Squibb Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Celldex Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celldex Therapeutics Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Celldex Therapeutics Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Celltrion Basic Information, Head Office, Major Market Areas and Its Competitors
Table Celltrion Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Celltrion Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table Daiichi Sankyo Basic Information, Head Office, Major Market Areas and Its Competitors
Table Daiichi Sankyo Breast Cancer Monoclonal Antibodies Revenue and Gross Margin (2016-2018)
Figure Daiichi Sankyo Breast Cancer Monoclonal Antibodies Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Head Office, Major Market Areas and Its Competitors
Table Immunomedics Basic Information, Head Office, Major Market Areas and Its Competitors
Table MacroGenics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Oncothyreon Basic Information, Head Office, Major Market Areas and Its Competitors
Table Pfizer Basic Information, Head Office, Major Market Areas and Its Competitors
Table Puma Biotechnology Basic Information, Head Office, Major Market Areas and Its Competitors
Table Seattle Genetics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sun Pharmaceutical Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table Synta Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors